PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2008 2009
THIS IS AN ONGOING ACTIVITY. THE NARRATIVE IS UNCHANGED EXCEPT FOR UPDATED
REFERENCES TO TARGETS AND BUDGETS.
+ The only change to the program since approval in the 2007 COP is that Columbia will use $500,000 to
procure formulary of seven essential OI drugs including CTX, multivitamins, anti-fungals, acyclovir, anti-
malarials and other HIV specific treatments/prophylaxis for 50,000 individuals to delay disease progression
and reduce morbidity and mortality. This will provide flexibility for contingencies for the national OI drug
procurement described under the Mission Competitive Procurement/TBD narrative.
1. LIST OF RELATED ACTIVITIES
This activity relates to activities in TB/HIV (#8846), ARV services (#6866), ARV Services (#6867), and
PMTCT (#7016).
2. ACTIVITY DESCRIPTION
Columbia University's International Centre for AIDS Care and Treatment (CU-ICAP) will increase and
strengthen its support from 12 to 35 sites in Central Province in the provision of palliative care services.
These activities will support palliative care services to 30,000 patients with HIV, including 3000 children. CU
-ICAP will establish/enhance care and treatment networks centered at the provincial hospital and larger
district hospitals in Central Province and extend a collaborative relationship with Jomo Kenyatta University
of Agriculture and Technology (JKUAT) to allow for creation of a regional university-based training and
technical support program. The collaboration offers an opportunity to develop quality assurance capacity on
all levels (laboratory, pharmacy, clinical expertise), provides a forum for strategic planning for effective care
and treatment programs, and informs targeted evaluation and strategic information needs. CU-ICAP will
continue to work closely with the Provincial ART Officer for Central Province, for example supporting regular
meetings of care providers in the area. Funds will continue to be used to support additional staff salaries in
accordance with Emergency Plan guidance, renovations and equipment needed to provide treatment,
disposable supplies, drugs for prevention and treatment of opportunistic infections, laboratory reagents, and
the costs of supportive supervision and advanced training in HIV care and treatment for 60 health care
workers. CU-ICAP supports the development of high quality HIV care and treatment services in low-
resource settings. CU-ICAP programs currently support HIV/AIDS activities in 11 African countries. In
Kenya, CU- ICAP has established a foundation for HIV/AIDS program activities, including PMTCT-Plus and
care and treatment. With regionalized planning for care and treatment services, CU- ICAP-Kenya was
designated the primary United States Government (USG) care and treatment partner for the Central
Province. CU-ICAP has established an efficient administrative and operations base in Nairobi and is
working closely with CDC-Kenya.
3. CONTRIBUTIONS TO OVERALL PROGRAM AREA
These activities will contribute to expansion of palliative care for clinically qualified HIV-positive patients,
strengthened human resource capacity to deliver HIV care, and a strengthened referral network for
provision of care services for people with HIV/AIDS.
4. LINKS TO OTHER ACTIVITIES
This activity links to ARV services (#6866, #6867)) and TB/HIV services (#8846), supported by Columbia
University and coordination of ARV scale-up activities supported through the National AIDS and STD
Control Program (NASCOP). Palliative care services will also link to PMTCT services (#7016) supported
through Pathfinder International, through the linkage of care to HIV positive women identified through the
PMTCT program.
5. POPULATIONS BEING TARGETED
These activities target people (adults, children, infants) living with HIV/AIDS. Services for children with HIV
are being established or expanded at all sites. Public health care providers, including doctors, nurses,
pharmacists, and laboratory workers are targeted for increased HIV care and treatment knowledge and
skills. The program will also continue to support treatment for HIV-infected students at JKUAT. These youth
are among an important focus population identified in Kenya's 5-year strategic plan for Emergency Plan
Implementation.
6. KEY LEGISLATIVE ISSUES ADDRESSED
This activity addresses legislative issues related to stigma and discrimination through community
sensitization activities.
7. EMPHASIS AREAS
This activity includes minor emphasis in commodity procurement, community mobilization, human
resources, development of networks/linkages/referral systems, human resources, local organization
capacity development, quality assurance and supportive supervision, strategic information, and training.
1.LIST OF RELATED ACTIVITIES
This activity relates to activities in Palliative Care (#6868), ARV Services (#6866, 6867) and PMTCT
(#7016).
2.ACTIVITY DESCRIPTION
Columbia University's International Center for AIDS Treatment (CU-ICAP) will support TB/HIV services for
patients at 35 sites in Central Province. Intensified TB screening will be offered to 15,000 HIV patients and
HIV screening for 3000 TB patients as part of the standard of care in all the facilities; approximately 1,500
co-infected patients are expected to be identified. Funds will support refresher training of laboratory staff
and improvement of basic laboratory microbiology capacity in order to meet the increased needs of TB
testing. 30 health care workers will be trained to provide clinical prophylaxis and/or treatment for TB to HIV-
infected individuals. CU-ICAP will maintain data concerning the numbers of people served and will report
both nationally and through the Emergency Plan. CU-ICAP supports the development of high quality HIV
care and treatment services in low resource settings. CU-ICAP programs currently support HIV/AIDS
activities in 11 African countries. In Kenya, CU-ICAP has established a foundation for HIV/AIDS program
activities, including PMTCT plus and care and treatment. With regionalized planning for care and treatment
services, CU-ICAP-Kenya was designated the primary USG care and treatment partner for central province.
CU-ICAP has established an efficient administrative and operations base in Nairobi and is working closely
with CDC-Kenya.
3.CONTRIBUTIONS TO OVERALL PROGRAM AREA
These activities will contribute towards the provision of integrated HIV/TB care for dually infected patients
by reducing TB morbidity and mortality in HIV-infected individuals and also reducing HIV related morbidity
and mortality in TB patients co-infected with HIV. These activities will strengthen referral systems, improve
diagnostics and treatment of TB among HIV-positive patients and strengthen capacity of health workers to
provide integrated HIV and TB services
4.LINKS TO OTHER ACTIVITIES
The overall program activity links closely to Palliative Care (#6868) and ARV Services (#6866, 6867)
currently supported by Columbia University and PMTCT services(#7016) offered by Pathfinder International.
5.POPULATIONS BEING TARGETED
These activities target people living with HIV/AIDS. Public health care providers, including doctors, nurses,
pharmacists, laboratory workers will receive training in the diagnosis and management of TB using
government guidelines.
6.KEY LEGISLATIVE ISSUES ADDRESSED
7.EMPHASIS AREAS
This activity includes minor emphases in commodity procurement, community mobilization, development of
networks/linkages/referral systems, human resources, local organization capacity development, quality
assurance, quality improvement and supportive supervision, strategic information, and training.
This activity relates to activities in ARV Drugs and ARV Services.
Columbia University's International Centre for AIDS Care and Treatment (CU-ICAP) will assist with
forecasting and procurement of additional drugs needed to treat 160,000 Kenyans with ARVs. Two other
major partners - Mission competitive procurement/TBD, Management Systems for Health/Rational
Pharmaceutical Management Plus (MSH/RPM Plus) will maintain primary responsibility for procurement
and distribution of pharmaceuticals nationally and under the Emergency Plan. Together with USG staff in
country, these major partners are primarily responsible for quantification and tracking for ARVs procured
with Emergency Plan funds. This alternate procurement mechanism through CU-ICAP and KEMRI will allow
some flexibility that will help to continue to avoid stock outs and treatment interruptions.
These activities are essential to maintaining a full and uninterrupted supply of HIV/AIDS related
pharmaceuticals and commodities.
These activities will coordinate with other partners involved in ARV drugs, Mission Competitive
Procurement/TBD, KEMSA, MEDS, MSH/RPM Plus, and complement and link with all activities listed in the
ARV services program area.
This activity targets men, women, and children with HIV.
6. EMPHASIS AREAS
This activity includes a major emphasis in commodity procurement.
Updated August 2008 reprogramming: this figure includes $100,000 for PwP. N/A (exempt)
